Literature DB >> 29111846

Investigation of CAV1/CAV2 rs4236601 and CDKN2B-AS1 rs2157719 in primary open-angle glaucoma patients from Brazil.

Hugo Freire Nunes1, Galina Ananina1, Vital Paulino Costa2, Nilson Ivo Tonin Zanchin3, José Paulo Cabral de Vasconcellos2, Mônica Barbosa de Melo1.   

Abstract

Large-scale genome-wide association studies have identified several susceptibility variants associated with the risk of primary open-angle glaucoma (POAG), among which rs4236601 (CAV1/CAV2) at chromosome 7q31 and rs2157719 at chromosome 9p21 (CDKN2B-AS1). The purpose of this study was to investigate whether these variants contribute to the incidence of POAG in a sample of the Brazilian Southeastern population and to determine the best-fitted genetic model for these single nucleotide polymorphisms (SNPs). A case-control study with 557 individuals, 310 with POAG, and 247 controls was conducted through PCR and direct sequencing. We observed a significant effect of the heterozygous genotype (G/A) of rs2157719 that occurred more frequently in the control group (p = 0.0004; OR: 0.517, CI 95%: 0.357-0.745). Allele frequencies also differed between cases and controls (p = 0.006; OR: 0.694, CI 95%: 0.522-0.922) with the best-fitted genetic model for rs2157719 being the codominant model. No differences were observed for genotype and allele distributions in relation to rs4236601 in the CAV1/CAV2 region. The association of rs2157719 (CDKN2B-AS1) with the POAG phenotype corroborates previously published results, reinforcing the importance of this variant in POAG etiology.

Entities:  

Keywords:  CAV1/CAV2; CDKN2B-AS1; POAG; caveolin; cyclin-dependent kinase; glaucoma; rs2157719; rs4236601

Mesh:

Substances:

Year:  2017        PMID: 29111846     DOI: 10.1080/13816810.2017.1393830

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  7 in total

1.  Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.

Authors:  Lauren K Wareham; Ana C Dordea; Grigorij Schleifer; Vincent Yao; Annabelle Batten; Fei Fei; Joseph Mertz; Meredith Gregory-Ksander; Louis R Pasquale; Emmanuel S Buys; Rebecca M Sappington
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

2.  A comprehensive map of disease networks and molecular drug discoveries for glaucoma.

Authors:  Haixin Wang; Yanhui Deng; Ling Wan; Lulin Huang
Journal:  Sci Rep       Date:  2020-06-16       Impact factor: 4.379

3.  Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner.

Authors:  Mojdeh Abbasi; Vivek K Gupta; Nitin Chitranshi; Veer Gupta; Reza Ranjbaran; Rashi Rajput; Kanishka Pushpitha; Devaraj Kb; Yuyi You; Ghasem Hosseini Salekdeh; Robert G Parton; Mehdi Mirzaei; Stuart L Graham
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

4.  Genetic association between CDKN2B-AS1 polymorphisms and the susceptibility of primary open-angle glaucoma (POAG): a meta-analysis from 21,775 subjects.

Authors:  Shanshan Liu; Siwen Chen; Tongtong Niu
Journal:  Ir J Med Sci       Date:  2021-10-14       Impact factor: 2.089

Review 5.  The Genetic and Endoplasmic Reticulum-Mediated Molecular Mechanisms of Primary Open-Angle Glaucoma.

Authors:  Wioletta Rozpędek-Kamińska; Radosław Wojtczak; Jacek P Szaflik; Jerzy Szaflik; Ireneusz Majsterek
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

6.  Identification of lncRNA-miRNA-mRNA regulatory network associated with primary open angle glaucoma.

Authors:  Minwen Zhou; Bing Lu; Wei Tan; Mingshui Fu
Journal:  BMC Ophthalmol       Date:  2020-03-16       Impact factor: 2.209

Review 7.  Molecular Genetics of Glaucoma: Subtype and Ethnicity Considerations.

Authors:  Ryan Zukerman; Alon Harris; Alice Verticchio Vercellin; Brent Siesky; Louis R Pasquale; Thomas A Ciulla
Journal:  Genes (Basel)       Date:  2020-12-31       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.